|
Index of reports
> Cases with Dyspnoea (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Arzerra (Ofatumumab) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Arzerra side effects in 86 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 86 year old female, weighing 69.1 kg (152.0 pounds)
Reactions: Dyspnoea, Hypertension, Oxygen Saturation Decreased, Infusion Related Reaction
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Diphenhydramine Hydrochloride; Acetaminophen; Procrit; Solu-Cortef
Possible Arzerra side effects in 86 year old female
Reported by a consumer/non-health professional from United States on 2012-07-19
Patient: 86 year old female
Reactions: Dyspnoea, Hypertension, Oxygen Saturation Decreased, Infusion Related Reaction
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Solu-Cortef; Diphenhydramine HCL; Procrit; Acetaminophen
Possible Arzerra side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient: male
Reactions: Dyspnoea, Infusion Related Reaction
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 84 year old male
Reported by a consumer/non-health professional from United States on 2012-04-09
Patient: 84 year old male, weighing 73.2 kg (161.0 pounds)
Reactions: Dyspnoea, Pruritus, Chest Pain, Hypotension
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-03
Patient: female, weighing 59.9 kg (131.7 pounds)
Reactions: Weight Decreased, Productive Cough, Dyspnoea, Pneumonia, Wheezing, Allergy To Animal, Speech Disorder, Lung Disorder, Fatigue, Activities of Daily Living Impaired, Sinus Disorder, NO Therapeutic Response, Anosmia, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Arzerra
|
